Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Pain D010146 64 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Burns D002056 34 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Infertility, Male D007248 11 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Brain Injuries D001930 4 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Peritonitis D010538 38 associated lipids
Hemorrhage D006470 15 associated lipids
Proteinuria D011507 30 associated lipids
Spasm D013035 5 associated lipids
Lymphoma D008223 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Thalassemia D013789 8 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Cholestasis D002779 23 associated lipids
Fibrosis D005355 23 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Glomerulonephritis D005921 35 associated lipids
Nervous System Diseases D009422 37 associated lipids
Psoriasis D011565 47 associated lipids
Brain Edema D001929 20 associated lipids
Leukopenia D007970 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Burns, Inhalation D002059 4 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemia D007511 18 associated lipids
Colonic Diseases D003108 5 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Michibayashi T Platelet aggregation and vasoconstriction related to platelet cyclooxygenase and 12-lipoxygenase pathways. 2005 J. Atheroscler. Thromb. pmid:16020916
Owen JS et al. An improved assay for platelet-activating factor using HPLC-tandem mass spectrometry. 2005 J. Lipid Res. pmid:15520455
Lemieux C et al. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. 2005 Blood pmid:15498854
Bazan HE Cellular and molecular events in corneal wound healing: significance of lipid signalling. 2005 Exp. Eye Res. pmid:15781273
Choi IW et al. TNF-alpha induces the late-phase airway hyperresponsiveness and airway inflammation through cytosolic phospholipase A(2) activation. 2005 J. Allergy Clin. Immunol. pmid:16159621
Burgos RA et al. 14-deoxyandrographolide as a platelet activating factor antagonist in bovine neutrophils. 2005 Planta Med. pmid:16041644
Caplan MS et al. The role of PAF, TLR, and the inflammatory response in neonatal necrotizing enterocolitis. 2005 Semin. Pediatr. Surg. pmid:16084401
Denizot Y et al. Platelet-activating factor and liver metastasis of colorectal cancer. 2005 Int. J. Cancer pmid:15455343
Shindou H et al. Priming effect of lipopolysaccharide on acetyl-coenzyme A:lyso-platelet-activating factor acetyltransferase is MyD88 and TRIF independent. 2005 J. Immunol. pmid:16002720
Black S et al. An intact phosphocholine binding site is necessary for transgenic rabbit C-reactive protein to protect mice against challenge with platelet-activating factor. 2005 J. Immunol. pmid:16002722
Koch E Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts. 2005 Phytomedicine pmid:15693702
Jantan I et al. Platelet-activating factor (PAF) receptor-binding antagonist activity of Malaysian medicinal plants. 2005 Phytomedicine pmid:15693713
El-Medany A et al. Attenuation of bleomycin-induced lung fibrosis in rats by mesna. 2005 Eur. J. Pharmacol. pmid:15713430
Ninio E Phospholipid mediators in the vessel wall: involvement in atherosclerosis. 2005 Curr Opin Clin Nutr Metab Care pmid:15716789
Evans L et al. A pharmacokinetic/pharmacodynamic model for a platelet activating factor antagonist based on data arising from Phase I studies. 2005 J. Pharm. Pharmacol. pmid:15720781
Yoshida H et al. Platelet-activating factor enhances the expression of nerve growth factor in normal human astrocytes under hypoxia. 2005 Brain Res. Mol. Brain Res. pmid:15661369
Zhu L and He P Platelet-activating factor increases endothelial [Ca2+]i and NO production in individually perfused intact microvessels. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15665052
Cuschieri J et al. Calcium/calmodulin-dependent kinase II is required for platelet-activating factor priming. 2005 Shock pmid:15665723
Roudebush WE et al. The significance of platelet-activating factor and fertility in the male primate: a review. 2005 J. Med. Primatol. pmid:15667340
Ottino P et al. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. 2005 Invest. Ophthalmol. Vis. Sci. pmid:15671273
Hidalgo MA et al. Andrographolide interferes with binding of nuclear factor-kappaB to DNA in HL-60-derived neutrophilic cells. 2005 Br. J. Pharmacol. pmid:15678086
Oku H et al. Inhibitory effects of xanthones from guttiferae plants on PAF-induced hypotension in mice. 2005 Planta Med. pmid:15678383
Lin P et al. Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. 2005 J. Immunol. pmid:15728511
Shimada T et al. Platelet-activating factor acts on cortisol secretion by perfused guinea-pig adrenals via calcium-/phospholipid-dependent mechanisms. 2005 J. Endocrinol. pmid:15684346
Yasu T et al. Activated leukocytes and endothelial cells enhance retention of ultrasound contrast microspheres containing perfluoropropane in inflamed venules. 2005 Int. J. Cardiol. pmid:15686774
Fell JM Neonatal inflammatory intestinal diseases: necrotising enterocolitis and allergic colitis. 2005 Early Hum. Dev. pmid:15707723
Schaloske RH et al. Molecular characterization of the lipopolysaccharide/platelet activating factor- and zymosan-induced pathways leading to prostaglandin production in P388D1 macrophages. 2005 Biochim. Biophys. Acta pmid:15708354
Mann NS and Leung JW Pathogenesis of esophageal rings in eosinophilic esophagitis. 2005 Med. Hypotheses pmid:15617859
Cheng L et al. Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis. 2005 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:15890711
Cheng L et al. Hydrogen peroxide reduces lower esophageal sphincter tone in human esophagitis. 2005 Gastroenterology pmid:16285965
Medvedev IN and GromnatsiÄ­ NI [The influence of nebivolol on thrombocyte aggregation in patients with arterial hypertension with metabolic sydrome]. 2005 Klin Med (Mosk) pmid:15881638
Rastelli VM et al. Influence of insulin on the microvascular response to inflammatory mediators in neonatal streptozotocin diabetic rats. 2005 Inflamm. Res. pmid:15883740
Ko HM et al. Involvement of matrix metalloproteinase-9 in platelet-activating factor-induced angiogenesis. 2005 FEBS Lett. pmid:15848174
Hardy P et al. New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy. 2005 Prostaglandins Leukot. Essent. Fatty Acids pmid:15850712
Chen LW et al. Different pathways leading to activation of extracellular signal-regulated kinase and p38 MAP kinase by formyl-methionyl-leucyl-phenylalanine or platelet activating factor in human neutrophils. 2005 J. Biomed. Sci. pmid:15917990
Goldring WP et al. Novel phomactin analogues as PAF receptor ligands. 2005 Bioorg. Med. Chem. Lett. pmid:15922596
Tombul T et al. Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction. 2005 J Clin Neurosci pmid:15925775
Boccellino M et al. Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility. 2005 Am. J. Pathol. pmid:15855650
Schram MT et al. Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. 2005 Hypertension pmid:15851628
Denizot Y et al. Platelet-activating factor and human thyroid cancer. 2005 Eur. J. Endocrinol. pmid:15994743
Fulkerson PC et al. CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism. 2005 Blood pmid:15802529
Androulakis N et al. Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation. 2005 J. Lipid Res. pmid:15995176
Grypioti AD et al. Platelet-activating factor (PAF) involvement in acetaminophen-induced liver toxicity and regeneration. 2005 Arch. Toxicol. pmid:15995853
Chatterjee BE et al. Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. 2005 J. Leukoc. Biol. pmid:16000391
Guo NJ et al. [Activation of platelet-neutrophil mediated by platelet-activating factor]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:15972139
Souza DG and Teixeira MM The balance between the production of tumor necrosis factor-alpha and interleukin-10 determines tissue injury and lethality during intestinal ischemia and reperfusion. 2005 Mem. Inst. Oswaldo Cruz pmid:15962100
Castro Faria Neto HC et al. Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase. 2005 Mem. Inst. Oswaldo Cruz pmid:15962103
White DC et al. Feasibility of assessment of regulatory lipids in breath condensate as potential presymptomatic harbingers of pulmonary pathobiology. 2005 J. Microbiol. Methods pmid:15963585
Jeon SY et al. Rat model of platelet-activating factor-induced rhinosinusitis. 2005 Ann. Otol. Rhinol. Laryngol. pmid:15966528
Tiemann U et al. Influence of ovarian steroid hormones or platelet-activating factor on mRNA of platelet-activating factor receptor in endometrial explant perfusion cultures from ovariectomized bovine. 2005 Prostaglandins Other Lipid Mediat. pmid:15967160
Lang KS et al. Mechanisms of suicidal erythrocyte death. 2005 Cell. Physiol. Biochem. pmid:15956782
Kita Y et al. A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry. 2005 Anal. Biochem. pmid:15958190
Fang YH et al. [Relationship between serum vWF and PAF in type 2 diabetic patients and diabetic nephropathy]. 2005 Di Yi Jun Yi Da Xue Xue Bao pmid:15958323
Vinson SM et al. Neutrophil adherence to bladder microvascular endothelial cells following platelet-activating factor acetylhydrolase inhibition. 2005 J. Pharmacol. Exp. Ther. pmid:15937147
Sumita C et al. Platelet activating factor induces cytoskeletal reorganization through Rho family pathway in THP-1 macrophages. 2005 FEBS Lett. pmid:16004986
Echazarreta AL et al. Lack of systemic oxidative stress during PAF challenge in mild asthma. 2005 Respir Med pmid:15823446
Cao HC et al. Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis. 2005 World J. Gastroenterol. pmid:16437644
Chen C and Bazan NG Lipid signaling: sleep, synaptic plasticity, and neuroprotection. 2005 Prostaglandins Other Lipid Mediat. pmid:16099392
Vardar S et al. Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats. 2005 J. Periodontol. pmid:15830643
Rubin BB et al. Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity. 2005 J. Biol. Chem. pmid:15475363
Uhlig S et al. Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung. 2005 Pharmacol Rep pmid:16415501
Zinchuk O et al. Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis. 2005 Mol. Vis. pmid:15735601
Asai Y Formation of spherical micelles composed of the novel platelet activating factor receptor antagonist, E5880. 2005 Pharmazie pmid:15801673
Nacken W et al. S100A9 deficiency alters adenosine-5'-triphosphate induced calcium signalling but does not generally interfere with calcium and zinc homeostasis in murine neutrophils. 2005 Int. J. Biochem. Cell Biol. pmid:15778088
Minnear FL et al. Sphingosine 1-phosphate prevents platelet-activating factor-induced increase in hydraulic conductivity in rat mesenteric venules: pertussis toxin sensitive. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15778280
Perry SW et al. HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis. 2005 J. Immunol. pmid:15778398
Ishiura Y et al. In vivo PAF-induced airway eosinophil accumulation reduces bronchial responsiveness to inhaled histamine. 2005 Prostaglandins Other Lipid Mediat. pmid:15789611
Gaudreault E et al. Involvement of leukotriene B4 receptor 1 signaling in platelet-activating factor-mediated neutrophil degranulation and chemotaxis. 2005 Prostaglandins Other Lipid Mediat. pmid:15789613
Calcerrada MC et al. Selective translocation of protein kinase c isozymes by PAF in rabbit platelets. 2005 Prostaglandins Other Lipid Mediat. pmid:15789614
Hudry-Clergeon H et al. Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase. 2005 FASEB J. pmid:15791001
Ersoy B et al. The role of platelet-activating factor in pathogenesis of type 1 diabetes. 2005 Diabetes Care pmid:15793212
Grigoriou O et al. Effect of sperm treatment with exogenous platelet-activating factor on the outcome of intrauterine insemination. 2005 Fertil. Steril. pmid:15749490
Cheng HH et al. Defect in regulation of Ca2+ movement in platelets from patients with systemic lupus erythematosus. 2005 Pharmacology pmid:15591819
Penna C et al. Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15637120
Connelly PW et al. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite. 2005 Free Radic. Biol. Med. pmid:15607900
Ivanov AI et al. Albumin is not an irreplaceable carrier for amphipathic mediators of thermoregulatory responses to LPS: compensatory role of alpha1-acid glycoprotein. 2005 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:15576666
Denizot Y et al. Platelet-activating factor does not stimulate cAMP formation from immature forms of freshly isolated leukaemic blasts. 2005 Leuk. Lymphoma pmid:15621790
Tran KC et al. Induction of angiogenesis by platelet-activating factor in the rat striatum. 2005 Neuroreport pmid:16148749
Milias GA et al. Effects of eccentric exercise-induced muscle injury on blood levels of platelet activating factor (PAF) and other inflammatory markers. 2005 Eur. J. Appl. Physiol. pmid:16151835
Hauser CJ et al. Non-specific effects of 4-chloro-m-cresol may cause calcium flux and respiratory burst in human neutrophils. 2005 Biochem. Biophys. Res. Commun. pmid:16168959
Kihara Y et al. Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor. 2005 J. Exp. Med. pmid:16172262
Tian X and Bazan NG Neuroprotection by platelet-activating factor antagonism. 2005 Ann. N. Y. Acad. Sci. pmid:16179552
Zhang Q et al. Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. 2005 J. Clin. Invest. pmid:16184199
Pexa A and Deussen A Modulation of ecto-5'-nucleotidase by phospholipids in human umbilical vein endothelial cells (HUVEC). 2005 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16200394
Nagata M et al. Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils. 2005 Int. Arch. Allergy Immunol. pmid:15947477
Chang GT et al. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation. 2005 J Ethnopharmacol pmid:16125889
Iversen VV et al. Platelet activating factor (PAF) increases plasma protein extravasation and induces lowering of interstitial fluid pressure (P) in rat skin. 2005 Acta Physiol. Scand. pmid:16128692
Tunc SE et al. Platelet-activating factor and P-selectin activities in thrombotic and nonthrombotic Behçet's patients. 2005 Rheumatol. Int. pmid:15004723
Hu G et al. Isoflurane prevents platelets from enhancing neutrophil-induced coronary endothelial dysfunction. 2005 Anesth. Analg. pmid:16243978
Löhrke B et al. Polar phospholipids from bovine endogenously oxidized low density lipoprotein interfere with follicular thecal function. 2005 J. Mol. Endocrinol. pmid:16326838
Fragopoulou E et al. Characterization of acetyl-CoA: lyso-PAF acetyltransferase of human mesangial cells. 2005 Mediators Inflamm. pmid:16258193
Besana A et al. Lipids and two-pore domain K+ channels in excitable cells. 2005 Prostaglandins Other Lipid Mediat. pmid:16099395
Shibamoto T et al. Involvement of platelet-activating factor and leukotrienes in anaphylactic segmental venoconstriction in ovalbumin sensitized guinea pig livers. 2005 Prostaglandins Other Lipid Mediat. pmid:16303618
Vieira-de-Abreu A et al. Anti-allergic properties of the bromeliaceae Nidularium procerum: inhibition of eosinophil activation and influx. 2005 Int. Immunopharmacol. pmid:16275631
Bellizzi MJ et al. Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor. 2005 J. Clin. Invest. pmid:16276420
Yu P et al. Mitogen-activated protein kinases regulate platelet-activating factor-induced hyperpermeability. 2005 Microcirculation pmid:16284005
Buke AC et al. Tumor necrosis factor alpha and interleukin 6 productions in response to platelet-activating factor in chronic hepatitis B virus infection. 2004 Sep-Oct Med Princ Pract pmid:15316260
Chami O et al. Components of a platelet-activating factor-signaling loop are assembled in the ovine endometrium late in the estrous cycle. 2004 Am. J. Physiol. Endocrinol. Metab. pmid:15271646
Lu J et al. Platelet-activating factor-induced apoptosis is blocked by Bcl-2 in rat intestinal epithelial cells. 2004 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:14512286
Xu Y and Tao YX Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity. 2004 Neuroreport pmid:15076749